ELEVANCE HEALTH INC (ELV) Stock Overview
USA - NYSE:ELV - US0367521038 - Common Stock
ELV Key Statistics, Chart & Performance
The current stock price of ELV is 306.91 USD. In the past month the price decreased by -0.86%. In the past year, price decreased by -43.15%.
ELV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 13.78 | 315.07B | ||
| HUM | HUMANA INC | 13.88 | 33.12B | ||
| CNC | CENTENE CORP | 6.33 | 16.03B | ||
| MOH | MOLINA HEALTHCARE INC | 7.79 | 9.55B | ||
| HQY | HEALTHEQUITY INC | 26.43 | 8.01B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.23B | ||
| PGNY | PROGYNY INC | 37.51 | 1.90B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.61B | ||
| NEUE | NEUEHEALTH INC | N/A | 60.61M |
Related stock screener links
About ELV
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Company Info
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
ELEVANCE HEALTH INC / ELV FAQ
What is the stock price of ELEVANCE HEALTH INC today?
The current stock price of ELV is 306.91 USD. The price decreased by -1.56% in the last trading session.
What is the ticker symbol for ELEVANCE HEALTH INC stock?
The exchange symbol of ELEVANCE HEALTH INC is ELV and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ELV stock listed?
ELV stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ELEVANCE HEALTH INC stock?
28 analysts have analysed ELV and the average price target is 373.55 USD. This implies a price increase of 21.71% is expected in the next year compared to the current price of 306.91. Check the ELEVANCE HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ELEVANCE HEALTH INC worth?
ELEVANCE HEALTH INC (ELV) has a market capitalization of 69.11B USD. This makes ELV a Large Cap stock.
How many employees does ELEVANCE HEALTH INC have?
ELEVANCE HEALTH INC (ELV) currently has 103158 employees.
What are the support and resistance levels for ELEVANCE HEALTH INC (ELV) stock?
ELEVANCE HEALTH INC (ELV) has a support level at 274.65 and a resistance level at 318.66. Check the full technical report for a detailed analysis of ELV support and resistance levels.
Is ELEVANCE HEALTH INC (ELV) expected to grow?
The Revenue of ELEVANCE HEALTH INC (ELV) is expected to grow by 12.33% in the next year. Check the estimates tab for more information on the ELV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ELEVANCE HEALTH INC (ELV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ELV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ELV, evaluating the profitability, health, valuation and growth aspects
- ELEVANCE HEALTH INC (ELV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ELEVANCE HEALTH INC (ELV) Sales and EPS estimates to see what analysts future expectations are.
- ELEVANCE HEALTH INC (ELV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ELEVANCE HEALTH INC (ELV) Insider and Institutional Ownership to learn about the owners and their transactions.
- ELEVANCE HEALTH INC (ELV) Stock Chart to make your own analysis
- ELEVANCE HEALTH INC (ELV) Latest news and press-releases to stay up to date.
Does ELEVANCE HEALTH INC (ELV) stock pay dividends?
ELEVANCE HEALTH INC (ELV) has a dividend yield of 2.17%. The yearly dividend amount is currently 6.55. Check the full fundamental report for a detailed analysis of ELV dividend history, reliability and sustainability.
When does ELEVANCE HEALTH INC (ELV) report earnings?
ELEVANCE HEALTH INC (ELV) will report earnings on 2025-10-15, after the market close.
What is the Price/Earnings (PE) ratio of ELEVANCE HEALTH INC (ELV)?
The PE ratio for ELEVANCE HEALTH INC (ELV) is 9.29. This is based on the reported non-GAAP earnings per share of 33.02 and the current share price of 306.91 USD. Check the full fundamental report for a full analysis of the valuation metrics for ELV.
What is the Short Interest ratio of ELEVANCE HEALTH INC (ELV) stock?
The outstanding short interest for ELEVANCE HEALTH INC (ELV) is 1.4% of its float. Check the ownership tab for more information on the ELV short interest.
ELV Technical Analysis
ELV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ELV. ELV has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ELV Financial Highlights
Over the last trailing twelve months ELV reported a non-GAAP Earnings per Share(EPS) of 33.02. The EPS decreased by -6.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.83% | ||
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| Debt/Equity | 0.65 |
ELV Forecast & Estimates
28 analysts have analysed ELV and the average price target is 373.55 USD. This implies a price increase of 21.71% is expected in the next year compared to the current price of 306.91.
For the next year, analysts expect an EPS growth of -8.42% and a revenue growth 12.33% for ELV